GHK-CU 100MG

Copper Transport & "Redox Silencing"

GHK-Cu acts as a carrier peptide with high affinity for copper(II) ions (pKa = 16.44). The complex "silences" copper's redox activity, preventing Fenton reaction damage while delivering copper safely into cells — essential for enzymes like lysyl oxidase (collagen crosslinking) and superoxide dismutase (antioxidant defense).[3]

Key Signaling Pathways

Pathway	Mechanism	Effect
NF-κB/p38 MAPK	Inhibits phosphorylation of NF-κB p65 and p38 MAPK	Blocks nuclear translocation → suppresses TNF-α, IL-6 (Park et al., 2016)[4]
Nrf2/Keap1	Promotes Nrf2 dissociation from Keap1 → nuclear translocation	HO-1 transcription → antioxidant defense (Zhang et al., 2022)[5]
SIRT1/STAT3	Upregulates SIRT1 → deacetylates STAT3 → suppresses RORγt	Reduces Th17 inflammation; ↑ ZO-1/Occludin tight junctions (Mao et al., 2025)[6]
TGF-β	Context-dependent modulation	Restores in COPD lungs (Campbell et al., 2012); suppresses in scarring/fibrosis[7]

Ferritin Iron Blockade

GHK-Cu binds to ferritin channels → prevents Fe(II) release → reduces iron-catalyzed lipid peroxidation by 87% (Miller et al., 1990).[8]

Gene Modulation

GHK-Cu induces >50% change in expression of 31.2% of human genes. It resets gene expression to a "younger/healthier" state — suppressing inflammatory and metastatic genes while activating repair and remodeling genes. Analysis via the Broad Institute Connectivity Map confirmed GHK modulates >4,000 genes.[2][9]

ECM Synthesis

Stimulates Collagen I/III, elastin, GAGs, and decorin; modulates MMPs and TIMPs for balanced tissue remodeling.[10]

Anti-Cancer Activity

Reactivates apoptosis (caspases 3/7) in neuroblastoma, leukemia, and breast cancer cell lines. Reverses 70% of 54 metastasis genes in colon cancer via Connectivity Map analysis.[9]

Dose-Response: Biphasic

Collagen synthesis stimulation begins at 10⁻¹² M, peaks at 10⁻⁹ M (1 nanomolar), and disappears at higher concentrations. Systemic wound healing in animals at ~1.1 mg/kg — far below the toxic threshold (LD50 estimated ~23,000 mg in 70 kg human).[10][3]

GHK vs. GHK-Cu

Form	Key Difference
GHK (peptide alone)	Some efficacy (quenches lipid peroxidation by-products); copper complex required for most wound healing/gene effects
GHK-Cu	Full regenerative profile; "redox silences" copper for safe delivery; strong chelators abolish effects
HGK:Cu (analog)	SOD-mimetic activity 223-fold higher than native GHK-Cu

GHK-Cu research spans dermatology, wound healing, pulmonology, oncology, and neuroscience across 10+ indication categories:

1. Wound Healing & Tissue Regeneration — Accelerates contraction, re-epithelialization, collagen accumulation; reduces TNF-α and MMPs. 64.5% wound size reduction vs 28.2% control (Canapp et al., 2003).[11]
2. Dermatology & Anti-Aging — Tightens skin, improves elasticity/density/thickness; reduces wrinkles 55%; outperforms Vitamin C and retinoic acid for collagen production (70% vs 50% vs 40%).[12]
3. Hair Growth Stimulation — Enlarges follicle size, prolongs anagen phase; comparable to 5% minoxidil. MDCT approach: SALT score 40%→7.5%.[13]
4. COPD/Emphysema — Reverses emphysematous gene expression; restores TGF-β pathway in lung fibroblasts.[7]
5. Anti-Cancer & Metastasis Suppression — Connectivity Map identifies GHK as reverser of metastatic colon cancer gene signature; reactivates apoptosis in neuroblastoma/leukemia/breast cancer.[9]
6. DNA Repair & Radiation Recovery — Restores replicative vitality to irradiated fibroblasts; ↑ bFGF, VEGF.[14]
7. Antioxidant & Anti-Inflammatory — Neutralizes acrolein/4-HNE; blocks ferritin iron release (87% ↓ lipid peroxidation); suppresses NF-κB.[8]
8. Neuroprotection — Promotes nerve outgrowth; ↑ NGF, NT-3, NT-4; reduces anxiety/pain/aggression at 0.5 µg/kg.[15]
9. Bone Regeneration — Promotes reparative osteogenesis in fracture models at 0.5 µg/kg.[16]
10. Gastrointestinal Healing — 60% reduction in IBD severity (n=16); ulcerative colitis relief via SIRT1/STAT3 pathway.[6]
11. Connectivity Map Gene-Signature Profiling — A research workflow used in oncology and aging laboratories applies the Broad Institute's Connectivity Map (CMAP) to interrogate which transcriptional states GHK can reverse. Published analyses report that the tripeptide modulates expression of ~4,000 human genes by >50%, including reversal of ~70% of a 54-gene metastatic colon-cancer signature, and partial reversal of COPD-emphysema and Alzheimer's hippocampal signatures. This positions GHK-Cu as a model substrate for studying small-peptide control of large gene-network programs.[9]
12. Redox-Silenced Copper Delivery Studies — Bioinorganic chemistry investigations use GHK-Cu as a model carrier for delivering Cu(II) to cells without triggering Fenton-driven hydroxyl-radical generation. The N3O coordination sphere "silences" copper's redox cycling, allowing controlled handoff to enzymes like SOD3 and lysyl oxidase. This research informs the broader peptide-metal-complex field, including investigations of analog HGK:Cu (223-fold higher SOD-mimetic activity) and copper-binding PIP-tides.[3]
13. Ferritin Iron-Blockade and Lipid Peroxidation Research — Cell-free and cell-culture investigations use GHK-Cu to probe whether copper-tripeptide complexes can prevent iron release from ferritin and downstream membrane lipid peroxidation. Reports show 87% suppression of microsomal lipid peroxidation, providing a research tool for studying iron-driven oxidative stress in models of aging, ischemia-reperfusion, and neurodegeneration.[8]

Comparative Research Context

Within the matrix-remodeling and tissue-repair research domain, GHK-Cu is most directly compared with BPC-157 (gastric pentadecapeptide that drives angiogenesis via Egr-1/NAB2 and VEGFR2), TB-500 (thymosin beta-4 fragment that sequesters G-actin and accelerates cell migration), and thymosin alpha-1 (TLR-modulating immunopeptide). Where BPC-157 and TB-500 act primarily through actin/cytoskeletal and growth-factor pathways, GHK-Cu's mechanism is dominated by transcriptional reprogramming via copper-dependent gene regulation, making it a complementary research tool when investigators wish to dissect transcription-driven from structural-protein-driven repair phenotypes.